Imiglucerase (Cerezyme<sup>®</sup>) improves quality of life in patients with skeletal manifestations of Gaucher disease
Neal J. Weinreb, GM Pastores(New York University), Barry E. Rosenbloom(Tower Cancer Research Foundation), Ainu Prakash‐Cheng(Mount Sinai Medical Center), Katherine B. Sims(Massachusetts General Hospital), Jennifer Angell, J. A. Barranger(University of Pittsburgh), Alison Skrinar, Seymour Packman(University of California, San Francisco)
Cited by 104
Related Papers
Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper–transporting ATPase
|Nature Genetics|1993|1.4k
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
|Genetics in Medicine|2014|605
Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries
|Cell|2012|598
Agalsidase-Beta Therapy for Advanced Fabry Disease
|Annals of Internal Medicine|2007|565
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555